Dr. Martens plc
DOCMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $787,600 | $877,100 | $1,000,300 | $908,300 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Cost of Goods Sold | $275,900 | $374,200 | $436,400 | $366,200 |
| Gross Profit | $511,700 | $502,900 | $563,900 | $542,100 |
| % Margin | 65% | 57.3% | 56.4% | 59.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $100 | $0 | $0 | $0 |
| SG&A Expenses | $100 | $376,500 | $373,100 | $309,400 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $455,500 | $0 | $0 | $0 |
| Operating Expenses | $455,600 | $376,500 | $373,100 | $309,400 |
| Operating Income | $56,100 | $126,400 | $190,800 | $232,700 |
| % Margin | 7.1% | 14.4% | 19.1% | 25.6% |
| Other Income/Exp. Net | -$47,300 | -$33,400 | -$85,600 | -$18,400 |
| Pre-Tax Income | $8,800 | $93,000 | $159,400 | $214,300 |
| Tax Expense | $4,300 | $23,800 | $30,500 | $33,100 |
| Net Income | $4,500 | $69,200 | $128,900 | $181,200 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -45.8% | -27.8% | – |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| Weighted Avg Shares Out | 962,300 | 983,500 | 1,000,500 | 1,000,100 |
| Weighted Avg Shares Out Dil | 974,100 | 985,600 | 1,001,200 | 1,002,900 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,800 | $3,000 | $1,900 | $0 |
| Interest Expense | $29,200 | $32,200 | $18,700 | $15,000 |
| Depreciation & Amortization | $72,500 | $72,300 | $54,200 | $36,700 |
| EBITDA | $110,500 | $196,300 | $204,400 | $266,000 |
| % Margin | 14% | 22.4% | 20.4% | 29.3% |